financetom
Business
financetom
/
Business
/
Navigator Q2 Adjusted EPS, Operating Revenue Decrease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Navigator Q2 Adjusted EPS, Operating Revenue Decrease
Aug 12, 2025 1:55 PM

04:38 PM EDT, 08/12/2025 (MT Newswires) -- Navigator (NVGS) reported Q2 adjusted earnings Tuesday of $0.14 per diluted share, down from $0.35 a year earlier.

Two analysts polled by FactSet expected $0.40.

Operating revenue for the quarter ended June 30 was $129.6 million, down from $146.7 million a year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cidara Says Influenza Prevention Drug Meets Primary, Secondary Endpoints; Shares Jump Pre-Bell
Cidara Says Influenza Prevention Drug Meets Primary, Secondary Endpoints; Shares Jump Pre-Bell
Jun 23, 2025
08:06 AM EDT, 06/23/2025 (MT Newswires) -- Cidara Therapeutics ( CDTX ) said Monday that its phase 2b trial evaluating CD388, its long-acting antiviral for seasonal influenza prevention, met its primary and secondary endpoints. The study showed that a single dose of CD388 provided 76.1% protection at 450 mg, 61.3% at 300 mg, and 57.7% at 150 mg against symptomatic...
Leap Therapeutics' Colorectal Cancer Study Shows Significant Benefits; Workforce Cuts Coming
Leap Therapeutics' Colorectal Cancer Study Shows Significant Benefits; Workforce Cuts Coming
Jun 23, 2025
08:06 AM EDT, 06/23/2025 (MT Newswires) -- Leap Therapeutics ( LPTX ) said Monday its phase 2 sirexatamab colorectal cancer study demonstrated significant benefits in patients with high levels of DKK1, no prior exposure to anti-VEGF therapy, or liver metastasis. The study assessed sirexatamab in combination with bevacizumab and chemotherapy, compared to bevacizumab and chemotherapy, in patients with advanced microsatellite...
C&S Wholesale Grocers to buy SpartanNash in $1.77 billion deal
C&S Wholesale Grocers to buy SpartanNash in $1.77 billion deal
Jun 23, 2025
June 23 (Reuters) - C&S Wholesale Grocers on Monday agreed to buy food distributor SpartanNash ( SPTN ) for $1.77 billion, including debt, the companies said. (Reporting by Savyata Mishra in Bengaluru; Editing by Devika Syamnath) ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved